a-Bromo-γ-butyrolactone

CAS: 5061-21-2

Ref. 3D-FB04489

Produktinformation

• Name: a-Bromo-γ-butyrolactone
• Synonyme: 2-Bromo-4-hydroxybutyric acid-gamma-lactone, (3R)-3-bromodihydrofuran-2(3H)-one, (3S)-3-bromodihydrofuran-2(3H)-one, 2(3H)-Furanone, 3-bromodihydro-, 2-Bromo-4-Butanolide, 2-Bromo-4-butyrolactone, 2-Bromo-4-hydroxybutyric acid g-lactone, 2-Bromo-4-hydroxybutyric acid gamma-lactone, 2-Bromo-gamma-butyrolactone, 2-Bromo-γ-butyrolactone, 3-Bromo-2-oxotetrahydrofuran, 3-Bromo-4,5-dihydro-2(3H)-furanone, 3-Bromodihydro-2(3H)-furanone, 3-Bromooxolan-2-one, 3-Bromotetrahydrofuran-2-one, 3-bromodihydrofuran-2(3H)-one, Butyric acid, 2-bromo-4-hydroxy-, γ-lactone, Butyric acid, α-bromo-γ-hydroxy-, γ-lactone, NSC 11726, NSC 56959, a-Bromo-γ-butyrolatone, alfa-Bromo-gamma butyrolatone, Α-Bromo-R-Butyrolactone, α-Bromo-γ-butyrolactone, α-Bromobutyric acid γ-lactone

Beschreibung

a-Bromo-gamma-butyrolactone (BBAL) is a structural analog of gamma-hydroxybutyric acid, a drug used to treat narcolepsy and cataplexy. BBAL can be synthesized by reacting anhydrous sodium with a mixture of bromoacetic acid and acrylonitrile in the presence of potassium hydroxide. The reaction mechanism for this process is not fully understood but it is believed that a tautomerization may occur between the two possible structures: alpha and beta. This product has been shown to provide pain relief in animal models as well as improve symptoms of metabolic disorders such as diabetes mellitus type II.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 164.99 g/mol
• Formel: C₄H₅BrO₂
• Reinheit: Min. 95%
• Farbe/Form: Colourless To Pale Yellow Liquid